Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 84724 · Class III · American National Red Cross, Penn Jersey Region
Key facts
| Event ID | 84724 |
|---|---|
| Recall numbers | B-0330-2020 |
| Recalling firm | American National Red Cross, Penn Jersey Region |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood products, which were processed with expired reagents, were distributed. |
| Initiation date | Sep 10, 2019 |
| Report date | Mar 4, 2020 |
| Termination date | Feb 21, 2020 |
| City | Philadelphia |
| State | PA |
| Country | United States |
| FEI number | 2573021 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: